Lisa Gehtland

Lisa Gehtland is a physician and research public health analyst with interests in newborn screening systems and maternal and child health. She is Project Director of the NCATS-funded Innovation Cooperative Agreement entitled “Early Check: An Innovative Collaboration to Facilitate Pre-symptomatic Clinical Trials in Newborns.” She has experience with rare disease registries, newborn screening (NBS) for genetic disorders, and the development of new models of NBS programs. Dr. Gehtland serves as the program manager for the Clinical and Translational Science Award (CTSA) funded by the National Center for Advancing Translational Science (NCATS) that RTI holds in partnership with UNC-Chapel Hill. She is responsible for administration of the UNC-RTI Pilot Grant Program and coordination of research engagement between UNC-Chapel Hill and RTI across disciplines. Dr. Gehtland also serves as associate project director of the NBS Pilot Studies indefinite delivery, indefinite quantity (IDIQ) contract and associated Task Orders for a NBS pilot study for mucopolysaccharidosis type I and a NBS pilot study for X-linked adrenoleukodystrophy.